4M Therapeutics Reports Results from 4MT2001 GLP Safety Studies
11 Jun 2025 //
BUSINESSWIRE
4M Therapeutics to Present at APA and ASCP Annual Meetings
21 Apr 2025 //
BUSINESSWIRE
4M Therapeutics Gets $120K Grant to GSK3? in SYNGAP1 Disorders
12 Nov 2024 //
BUSINESSWIRE
4M Therapeutics’ Compounds to Be Utilized in Research Project
17 Oct 2024 //
BUSINESSWIRE